ctrl K

Entera Bio Ltd. (ENTX)

NASDAQ: ENTX · Real-Time Price · USD

2.21

0.04 (1.84%)

At close: May 01, 2025, 3:59 PM

2.25

1.81%

After-hours: May 01, 2025, 06:48 PM EDT

Entera Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	181K	n/a	134K	571K	365K	236K	500K	n/a	n/a
Cost of Revenue	172K	56K	101K	373K	209K	210K	n/a	43K	35K
Gross Profit	9K	-56K	33K	198K	156K	26K	500K	-43K	-35K
Operating Income	-9.59M	-8.89M	-13.02M	-12.22M	-11.13M	-11.45M	-10.86M	11.34M	-5.37M
Interest Income	n/a	31K	83K	n/a	28K	84K	n/a	n/a	n/a
Pretax Income	-9.53M	-8.86M	-12.93M	-12.25M	-9.96M	-10.79M	-10.3M	-11.2M	-1.2M
Net Income	-9.54M	-8.89M	-13.07M	-12.19M	-9.98M	-10.88M	-10.3M	-11.2M	-1.2M
Selling & General & Admin	5.09M	4.43M	7.25M	5.69M	4.89M	4.28M	2.84M	8.57M	2.72M
Research & Development	4.5M	4.51M	5.85M	6.77M	6.4M	7.2M	8.52M	2.77M	2.65M
Other Expenses	n/a	n/a	-51K	-46K	1.24M	743K	523K	n/a	n/a
Operating Expenses	9.59M	8.88M	13.05M	12.41M	11.29M	11.48M	11.36M	11.34M	5.37M
Interest Expense	n/a	n/a	n/a	29K	28K	84K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.77M	8.94M	13.15M	12.79M	11.5M	11.69M	11.36M	11.34M	5.37M
Income Tax Expense	14K	29K	137K	-59K	20K	84K	557K	-146K	n/a
Shares Outstanding (Basic)	37.65M	29.01M	28.81M	26.13M	18.42M	12.15M	7.96M	8.57M	8.57M
Shares Outstanding (Diluted)	37.65M	29.01M	28.81M	26.13M	18.42M	12.15M	7.98M	11.9M	11.9M
EPS (Basic)	-0.25	-0.31	-0.45	-0.47	-0.54	-0.9	-1.3	-1.31	-0.14
EPS (Diluted)	-0.25	-0.31	-0.45	-0.47	-0.54	-0.9	-1.29	-0.94	-0.1
EBITDA	-9.54M	-8.8M	-12.87M	-12.16M	-11.11M	-11.35M	-10.81M	-11.05M	-5.33M
EBIT	-9.59M	-8.86M	-13.02M	-12.22M	-11.17M	-11.45M	-10.86M	-11.09M	-1.06M
Depreciation & Amortization	46K	56K	64K	53K	63K	238K	54K	43K	35K